| 000 | 00897 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250512043646.0 | ||
| 264 | 0 | _c19890928 | |
| 008 | 198909s 0 0 eng d | ||
| 022 | _a0167-5699 | ||
| 024 | 7 |
_a10.1016/0167-5699(88)91301-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTorensma, R | |
| 245 | 0 | 0 |
_aLimiting HIV infectivity with peptides. _h[electronic resource] |
| 260 |
_bImmunology today _cSep 1988 |
||
| 300 |
_a255-6 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPeptides _xtherapeutic use |
| 650 | 0 | 4 | _aReceptors, HIV |
| 650 | 0 | 4 |
_aReceptors, Virus _xmetabolism |
| 700 | 1 | _avan der Bij, W | |
| 773 | 0 |
_tImmunology today _gvol. 9 _gno. 9 _gp. 255-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0167-5699(88)91301-1 _zAvailable from publisher's website |
| 999 |
_c3272901 _d3272901 |
||